Serum complement and familial combined hyperlipidemia

This publication has 20 references indexed in Scilit:

• Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
  Journal of Clinical Investigation, 1993
• Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion
  Metabolism, 1993
• Familial lipoprotein disorders in patients with premature coronary artery disease.
  Circulation, 1992
• Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions.
  The Journal of Experimental Medicine, 1990
• Association of serum IgA and C4 with severe atherosclerosis
  Atherosclerosis, 1988
• Activation of the human terminal complement pathway in atherosclerosis
  Clinical Immunology and Immunopathology, 1987
• Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
  Journal of Clinical Investigation, 1973
• FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASE
  The Lancet, 1973
• Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
  The American Journal of Medicine, 1973